Tenaya (TNYA): יחס P/E מותאם צמיחה

סמל ולוגו של המותג tenayatherapeutics.com (TNYA)

Tenaya Therapeutics (TNYA) relies on outsourcing production and testing to maintain operational flexibility. Transparent gene therapy management and patent protection are validated via the P/E ratio relative to medium-term growth on the GURU.Markets chart, where 0.00 indicates the level of this metric. A stable staff of leading cardiologists and GMP standards experts guarantees the company's technological progress.

מכפיל מחיר לרווח לצמיחה: Tenaya Therapeutics (TNYA) עבור 04.07.2022 - 16.11.2026

Tenaya (TNYA) - פילוחי מדדים ודוחות פיננסיים

- ציטוטים נוכחיים ותחזית שווי ממוצעת:
- נתוני שווי שוק בבורסה:
אנליטיקה מסכמת של החברה:Tenaya Therapeutics Inc
מוצר ממותג של Tenaya Therapeutics, Inc.

To select assets with a high margin of safety, the PEG ratio is utilized to measure the relationship between the P/E ratio and earnings growth rates, where values below one signal that a business is undervalued. In the case of Tenaya Therapeutics (TNYA), which focuses on innovative cardiac gene therapy, the growth-normalized P/E allows for an assessment of whether the market price is fair relative to the company's R&D phase potential.